TY - JOUR
T1 - Outcome in patients perceived as receiving excessive care across different ethical climates
T2 - a prospective study in 68 intensive care units in Europe and the USA
AU - the DISPROPRICUS study group of the Ethics Section of the European Society of Intensive Care Medicine
AU - Benoit, D. D.
AU - Jensen, H. I.
AU - Malmgren, J.
AU - Metaxa, V.
AU - Reyners, A. K.
AU - Darmon, M.
AU - Rusinova, K.
AU - Talmor, D.
AU - Meert, A. P.
AU - Cancelliere, L.
AU - Zubek, L.
AU - Maia, P.
AU - Michalsen, A.
AU - Vanheule, S.
AU - Kompanje, E. J.O.
AU - Decruyenaere, J.
AU - Vandenberghe, S.
AU - Vansteelandt, S.
AU - Gadeyne, B.
AU - Van den Bulcke, B.
AU - Azoulay, E.
AU - Piers, R. D.
AU - Spapen, Herbert
AU - Van Malderen, Marie Claire
AU - Opdenacker, Godelieve
AU - Meyfroidt, Geert
AU - Mesotten, Dieter
AU - Wauters, Joost
AU - Van Laer, Marie
AU - Wilmer, Alexander
AU - Wauters, Joost
AU - Ceunen, Helga
AU - De Laet, Inneke E.
AU - Jans, Anita
AU - Benoit, Dominique
AU - Oeyen, Sandra
AU - Herck, Ingrid
AU - Bracke, Stephanie
AU - Clauwaert, Charlotte
AU - Meert, Anne Pascale
AU - Leclercq, Nathalie
AU - Jacques, Devriendt
AU - Philippe, Dechamps
AU - Zykova, Ivana
AU - Malaska, Jan
AU - Schmidt, Matous
AU - Satinsky, Igor
AU - Kieslichova, Eva
AU - Krizova, Jarmila
AU - Wilson, Michael E.
N1 - Funding Information:
This study was supported by a European Society of Intensive Care Medicine/European Critical Care Research Network clinical research award and a Fonds voor Wetenschappelijk Onderzoek senior clinical investigators grant (1800513N) obtained in 2012 by DB. We are grateful to Ariella Van Sompel for having performed the factor and cluster analysis together with VDB and RP (under supervision of SVH and SVS) and Jolien Roels for having performed the data cleaning and the univariate analysis (under supervision of DB, SVB and SVS). Participating centers and local investigators: Belgium: University Hospital, Vrije Universiteit Brussel, Brussels (Herbert Spapen, Marie-Claire Van Malderen, Godelieve Opdenacker), Leuven University Hospital, Leuven (Geert Meyfroidt, Dieter Mesotten, Joost Wauters, Marie Van Laer and Alexander Wilmer, Joost Wauters, Helga Ceunen), ZNA Stuivenberg, Antwerpen (Inneke E De Laet, Anita Jans), Ghent University Hospital, Gent (Dominique Benoit, Sandra Oeyen, Ingrid Herck, Stephanie Bracke, Charlotte Clauwaert), Institut Jules Bordet, Bruxelles (Meert Anne-Pascale, Leclercq Nathalie), CHU-Brugmann, Bruxelles (Devriendt Jacques), CHU Saint Pierre, Bruxelles (Dechamps Philippe), Czech Republic: Liberec District Hospital, Liberec (Ivana Zykova), Masaryk University, Brno and University Hospital, Brno (Jan Malaska), Third Faculty of Medicine, Charles University, Prague (Matous Schmidt), Hospital and Polyclinic Havirov, Havirov (Igor Satinsky), Institute for Experimental and Clinical Medicine, Prague (Eva Kieslichova), 3rd Medical Department, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague (Jarmila Krizova), Karlovy Vary District Hospital, Karlovy Vary (Robert Janda), Pardubice District Hospital, Pardubice (Magdalena Fortova, Jiri Matyas), First Faculty of Medicine, Charles University and General University Hospital, Prague (Katerina Rusinova, Ondrej Kopecky), Denmark: Herning Hospital, Herning (Christian Alves Køhler Pedersen), Kolding Hospital, Kolding (Stine Hebsgaard), Vejle Hospital, Vejle (Rikke Frank Aagaard Johnsen), Holbæk Hospital, Holbæk (Tina Charlotte Bitsch Hansen), France: Saint-Etienne University Hospital and Jacques Lisfranc Medical School, Saint-Etienne (Michael Darmon), Saint-Louis University Hospital, APHP, Université Paris-7, Paris (Danielle Reuter, Elie Azoulay), Institut Paoli Calmette, Marseilles (Djamel Mokart), Montfermeil Hospital, Montfermeil (François Vincent), Germany: University Hospital Jena, Jena (Christiane S. Har-tog), Viersen General Hospital, Viersen (Peter Gretenkort), Tettnang Hospital, Tettnang (Andrej Michalsen), Greece: Agia Olga Hospital, Athens (Aikaterini Kounougeri), Evangelismos Hospital, Athens (Serafim Nanas), Agios Pavlos Hospital, Thessaloniki (Despina Papachristou), AHEPA University Hospital, Thessaloniki, (Ioanna Soultati), G.Gennimatas Hospital, Thessaloniki (Dimitrios Lathyris), Hippokratio General Hospital, Thessaloniki (Marili Pasakiotou), Papa-georgiou General Hospital, Thessaloniki (Marina Oikonomou), Hungary: Sem-melweis University Budapest, Budapest (Gábor Élő, Orsolya Szűcs), Kaposi Mór Teaching Hospital, Kaposvár University, Kaposvár (János Fogas), St. Stephen and St. Leslie Metropolitan Hospital, Budapest (Ilona Bobek), Italy: Azienda Ospedaliero Universitaria, “Maggiore della Carità”, Novara, and Department of Translational Medicine, Università del Piemonte Orientale, Novara (Francesco Della Corte, Carlo Olivieri, Rosanna Vaschetto, Laura Cancelliere), Ospedale Civile San Salvatore, and Department of Life, Health and Environmental Sciences (MeSVA), University of L’Aquila and Department of Emergency, San Salvatore Hospital, L’Aquila (Franco Marinangeli, Tullio Pozone, Alessandra Ciccozzi), The Netherlands: Canisius Wilhelmina Ziekenhuis, Nijmegen (A. Schouten, Monique Bruns), Medical Center Leeuwarden, Leeuwarden (Rik T. Gerritsen, Matty Koopmans), Erasmus University Hospital of Rotterdam (Erwin Kompanje, Ditty van Duijn), University of Groningen and University Medical Center Groningen, Groningen (Jan G. Zijlstra, Anne KL Reyners), Wilhelmina Ziekenhuis Assen, Assen (Johan G. Lutisan), Portugal: Hospital S.António, Porto (Raquel Monte, José António Pinho, Pedro Pimenta), CHVNG, Vila Nova de Gaia (Paula Fernandes, Ana Isabel Paixão), Instituto Português de Oncologia, Porto (Filomena Faria), Sweden: Sahlgrenska University Hospital, Gothenburg (Johan A. Malmgren), Sahlgrenska University Hospital/Östra, Gothenburg (Bertil Andersson), Skåne University Hospital, Malmö (Eva Åkerman), Karolinska University Hospital, Karolinska (Andreas Hvarfner), The Hospital of Norrköping, Norrköping (Robert Svensson), United Kingdom: King’s College Hospital, London (Victoria Metaxa), USA: Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA (Daniel Talmor, Ariel Mueller, Valerie Banner-Good-speed), Henry Mayo Newhall Memorial Hospital, Valencia, CA (Dee Rickett), Mayo Clinic, Rochester, MN (Michael E. Wilson, Richard Hinds).
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Purpose: Whether the quality of the ethical climate in the intensive care unit (ICU) improves the identification of patients receiving excessive care and affects patient outcomes is unknown. Methods: In this prospective observational study, perceptions of excessive care (PECs) by clinicians working in 68 ICUs in Europe and the USA were collected daily during a 28-day period. The quality of the ethical climate in the ICUs was assessed via a validated questionnaire. We compared the combined endpoint (death, not at home or poor quality of life at 1 year) of patients with PECs and the time from PECs until written treatment-limitation decisions (TLDs) and death across the four climates defined via cluster analysis. Results: Of the 4747 eligible clinicians, 2992 (63%) evaluated the ethical climate in their ICU. Of the 321 and 623 patients not admitted for monitoring only in ICUs with a good (n = 12, 18%) and poor (n = 24, 35%) climate, 36 (11%) and 74 (12%), respectively were identified with PECs by at least two clinicians. Of the 35 and 71 identified patients with an available combined endpoint, 100% (95% CI 90.0–1.00) and 85.9% (75.4–92.0) (P = 0.02) attained that endpoint. The risk of death (HR 1.88, 95% CI 1.20–2.92) or receiving a written TLD (HR 2.32, CI 1.11–4.85) in patients with PECs by at least two clinicians was higher in ICUs with a good climate than in those with a poor one. The differences between ICUs with an average climate, with (n = 12, 18%) or without (n = 20, 29%) nursing involvement at the end of life, and ICUs with a poor climate were less obvious but still in favour of the former. Conclusion: Enhancing the quality of the ethical climate in the ICU may improve both the identification of patients receiving excessive care and the decision-making process at the end of life.
AB - Purpose: Whether the quality of the ethical climate in the intensive care unit (ICU) improves the identification of patients receiving excessive care and affects patient outcomes is unknown. Methods: In this prospective observational study, perceptions of excessive care (PECs) by clinicians working in 68 ICUs in Europe and the USA were collected daily during a 28-day period. The quality of the ethical climate in the ICUs was assessed via a validated questionnaire. We compared the combined endpoint (death, not at home or poor quality of life at 1 year) of patients with PECs and the time from PECs until written treatment-limitation decisions (TLDs) and death across the four climates defined via cluster analysis. Results: Of the 4747 eligible clinicians, 2992 (63%) evaluated the ethical climate in their ICU. Of the 321 and 623 patients not admitted for monitoring only in ICUs with a good (n = 12, 18%) and poor (n = 24, 35%) climate, 36 (11%) and 74 (12%), respectively were identified with PECs by at least two clinicians. Of the 35 and 71 identified patients with an available combined endpoint, 100% (95% CI 90.0–1.00) and 85.9% (75.4–92.0) (P = 0.02) attained that endpoint. The risk of death (HR 1.88, 95% CI 1.20–2.92) or receiving a written TLD (HR 2.32, CI 1.11–4.85) in patients with PECs by at least two clinicians was higher in ICUs with a good climate than in those with a poor one. The differences between ICUs with an average climate, with (n = 12, 18%) or without (n = 20, 29%) nursing involvement at the end of life, and ICUs with a poor climate were less obvious but still in favour of the former. Conclusion: Enhancing the quality of the ethical climate in the ICU may improve both the identification of patients receiving excessive care and the decision-making process at the end of life.
KW - Decision-making
KW - Ethical climate
KW - Interdisciplinary collaboration
KW - Patient outcomes
KW - Perceived excessive care
KW - Treatment-limitation decisions
UR - http://www.scopus.com/inward/record.url?scp=85047662045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047662045&partnerID=8YFLogxK
U2 - 10.1007/s00134-018-5231-8
DO - 10.1007/s00134-018-5231-8
M3 - Article
C2 - 29808345
AN - SCOPUS:85047662045
SN - 0342-4642
VL - 44
SP - 1039
EP - 1049
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 7
ER -